Renaissance Technologies - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 122 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2020$950,000
-78.5%
31,600
-66.3%
0.00%
-66.7%
Q4 2019$4,418,00093,7790.00%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2020
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$53,209,00043.12%
Ponoi Management, LLC 1,880,623$63,565,00035.32%
Column Group LLC 2,626,631$88,780,00012.57%
Euclidean Capital LLC 554,325$18,736,0006.08%
Chicago Capital Management, LLC 295,878$10,001,0005.60%
COMMODORE CAPITAL LP 440,869$14,901,0005.19%
Samson Rock Capital LLP 467,072$15,787,0003.11%
S. MUOIO & CO. LLC 105,000$3,549,0003.01%
Omni Partners US LLC 1,815,117$61,351,0002.70%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 621,541$21,008,0002.68%
View complete list of CONSTELLATION PHARMCETICLS I shareholders